Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence. | [Pakistan Journal of Medical Sciences • 2015]

Author(s):

1. Ammara Mushtaq: Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan

2. Subika Khatoon: Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan

3. Muhammad Asif Qureshi: Dow Medical College, Dow University of Health Sciences, Karachi, Sindh, Pakistan

Abstract:

Idiopathic Pulmonary Haemosiderosis (IPH) is a rare disease commonly affecting the paediatric population with approximately 500 globally reported cases in the literature. The disease usually presentswith a symptom triad consisting of ferropenic anaemia, cough with haemoptysis and diffuse bilateral alveolar infiltrates. Therapeutic options for this disorder are not only limited but also not fully effective. Moreover, corticosteroids remain the mainstay of IPH treatment. This communication reviews the available evidence in support of corticosteriod usage in the treatment of IPH. We conclude that the use of corticosteroid in IPH treatment is unfathomed and demands further investigation.

Page(s): 487-489

DOI: DOI not available

Published: Journal: Pakistan Journal of Medical Sciences, Volume: 31, Issue: 2, Year: 2015

Keywords:

Keywords are not available for this article.

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views